FDA Advisory Committee Rejects Lilly/Alnara's Sollpura (liprotamase) for Pancreatic Enzyme Insufficiency January 3, 2011 Filed under: Trends-in-Medicine
FDA Panel Recommends Approval of Orexigen's Obesity Drug Contrave December 3, 2010 Filed under: Trends-in-Medicine